幹細胞市場：細胞源、タイプ、治療用途別-2023～2030年の世界予測

幹細胞の世界市場は、2023年に2億3,723万米ドル、CAGR16.89%で大きく成長し、2030年には7億840万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の幹細胞市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.幹細胞の世界市場規模および予測は？

2.予測期間中、世界の幹細胞市場を形成するCOVID-19の阻害要因と影響は？

3.幹細胞の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.幹細胞の世界市場における競争戦略は？

5.幹細胞の世界市場における技術動向と規制の枠組みは？

6.幹細胞の世界市場における主要ベンダーの市場シェアは？

7.幹細胞の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 効果的な疾患管理のための潜在的な幹細胞療法に関する意識の高まり
    • 高度なゲノムベースの細胞解析技術の採用
    • 幹細胞療法の開発への投資の増加
    • 幹細胞のバンキングと処理に関連するインフラ開発
  • 抑制要因
    • 商業化と開発のための大まかに定義された規制ガイドライン
    • 関連する社会倫理問題
  • 機会
    • 新興諸国支援的な規制
    • ESCの効果的な代替手段としてのIPSCの出現
  • 課題
    • 限られた技術専門家に関する懸念
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ
  • サプライチェーン分析

第6章 幹細胞市場：細胞源別

• イントロダクション
• 脂肪組織由来間葉系幹細胞
• 骨髄由来間葉系幹細胞
• 臍帯血/胚幹細胞

第7章 幹細胞市場：タイプ別

• イントロダクション
• 同種幹細胞療法
  • 急性移植片対宿主病
  • 筋骨格系疾患
  • 手術
  • 傷と怪我
• 自己由来
  • 心血管疾患
  • 消化器疾患
  • 傷と怪我

第8章 幹細胞市場：治療用途別

• イントロダクション
• 心血管疾患
• 消化器疾患
• 筋骨格系疾患
• 手術
• 傷と怪我

第9章 南北アメリカの幹細胞市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の幹細胞市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの幹細胞市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. STEM CELLS MARKET RESEARCH PROCESS
• FIGURE 2. STEM CELLS MARKET SIZE, 2022 VS 2030
• FIGURE 3. STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. STEM CELLS MARKET SIZE, BY CELL SOURCE, 2022 VS 2030 (%)
• FIGURE 5. STEM CELLS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 6. STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2022 VS 2030 (%)
• FIGURE 7. STEM CELLS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. STEM CELLS MARKET DYNAMICS
• FIGURE 9. STEM CELLS MARKET SIZE, BY CELL SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. STEM CELLS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. STEM CELLS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. STEM CELLS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 5. STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. STEM CELLS MARKET SIZE, BY BONE MARROW-DERIVED MESENCHYMAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. STEM CELLS MARKET SIZE, BY CORD BLOOD/EMBRYONIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 9. STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 10. STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. STEM CELLS MARKET SIZE, BY ACUTE GRAFT-VERSUS-HOST DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. STEM CELLS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. STEM CELLS MARKET SIZE, BY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. STEM CELLS MARKET SIZE, BY WOUNDS & INJURIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 16. STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. STEM CELLS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. STEM CELLS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. STEM CELLS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. STEM CELLS MARKET SIZE, BY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. STEM CELLS MARKET SIZE, BY WOUNDS & INJURIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. CANADA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 45. CANADA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 46. CANADA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. CHINA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 70. CHINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. CHINA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 72. CHINA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 73. CHINA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. INDIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 75. INDIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 77. INDIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 78. INDIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. ITALY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 161. ITALY STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. ITALY STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 163. ITALY STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 164. ITALY STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. POLAND STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 181. POLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. POLAND STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 183. POLAND STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 184. POLAND STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. QATAR STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 186. QATAR STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. QATAR STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 188. QATAR STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 189. QATAR STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 236. STEM CELLS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 237. STEM CELLS MARKET LICENSE & PRICING

The Global Stem Cells Market is forecasted to grow significantly, with a projected USD 237.23 million in 2023 at a CAGR of 16.89% and expected to reach a staggering USD 708.40 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Stem Cells Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Stem Cells Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Cell Source, market is studied across Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, and Cord Blood/Embryonic Stem Cells. The Cord Blood/Embryonic Stem Cells is projected to witness significant market share during forecast period.

Based on Type, market is studied across Allogeneic Stem Cell Therapy and Autologous. The Allogeneic Stem Cell Therapy is further studied across Acute Graft-Versus-Host Disease, Musculoskeletal Disorders, Surgeries, and Wounds & Injuries. The Autologous is further studied across Cardiovascular Diseases, Gastrointestinal Diseases, and Wounds and Injuries. The Autologous is projected to witness significant market share during forecast period.

Based on Therapeutic Application, market is studied across Cardiovascular Diseases, Gastrointestinal Diseases, Musculoskeletal Disorders, Surgeries, and Wounds & Injuries. The Surgeries is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Stem Cells Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Stem Cells Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Stem Cells Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Stem Cells Market?

4. What is the competitive strategic window for opportunities in the Global Stem Cells Market?

5. What are the technology trends and regulatory frameworks in the Global Stem Cells Market?

6. What is the market share of the leading vendors in the Global Stem Cells Market?

7. What modes and strategic moves are considered suitable for entering the Global Stem Cells Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Stem Cells Market, by Cell Source, 2022 vs 2030
• 4.3. Stem Cells Market, by Type, 2022 vs 2030
• 4.4. Stem Cells Market, by Therapeutic Application, 2022 vs 2030
• 4.5. Stem Cells Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing awareness related to the potential stem cell therapy for effective disease management
    • 5.1.1.2. Introduction of advanced Genome-based cell analysis techniques
    • 5.1.1.3. Increasing investment for the development of stem cell therapies
    • 5.1.1.4. Infrastructural development related to stem cell banking and processing
  • 5.1.2. Restraints
    • 5.1.2.1. Loosely defined regulatory guidelines for commercialization and development
    • 5.1.2.2. Associated social-ethical issues
  • 5.1.3. Opportunities
    • 5.1.3.1. Supportive regulations across developing countries
    • 5.1.3.2. Emergence of IPSCs as effective alternative to ESCs
  • 5.1.4. Challenges
    • 5.1.4.1. Concern regarding limited technical experts
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization
  • 5.9.1. Supply Chain Analysis

6. Stem Cells Market, by Cell Source

• 6.1. Introduction
• 6.2. Adipose Tissue-Derived Mesenchymal Stem Cells
• 6.3. Bone Marrow-Derived Mesenchymal Stem Cells
• 6.4. Cord Blood/Embryonic Stem Cells

7. Stem Cells Market, by Type

• 7.1. Introduction
• 7.2. Allogeneic Stem Cell Therapy
  • 7.2.1. Acute Graft-Versus-Host Disease
  • 7.2.2. Musculoskeletal Disorders
  • 7.2.3. Surgeries
  • 7.2.4. Wounds & Injuries
• 7.3. Autologous
  • 7.3.1. Cardiovascular Diseases
  • 7.3.2. Gastrointestinal Diseases
  • 7.3.3. Wounds and Injuries

8. Stem Cells Market, by Therapeutic Application

• 8.1. Introduction
• 8.2. Cardiovascular Diseases
• 8.3. Gastrointestinal Diseases
• 8.4. Musculoskeletal Disorders
• 8.5. Surgeries
• 8.6. Wounds & Injuries

9. Americas Stem Cells Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Stem Cells Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Stem Cells Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing